Companies Cryptocurrencies
CNS Pharmaceuticals Inc
CNS Pharmaceuticals Inc
Exchange: NasdaqCM
IPO Date: 08/11/2019
CEO: Mr. John Michael Climaco Esq., J.D.
Biotechnology Healthcare 🔗
  • CNSP
    symbol
  • price
  • market cap
  • changes
If you bought

shares of CNS Pharmaceuticals Inc (CNSP) on
You would have made
AMOUNT
today.
Old Price $12 Current Price $12

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. The company is headquartered in Houston, Texas and currently employs 1 full-time employees. The firm is focused on developing anticancer drug candidates for the treatment of brain and central nervous system tumors. The firm is focused on developing its lead drug candidate, Berubicin for the treatment of glioblastoma. Glioblastoma are tumors that arise from astrocytes, which are star-shaped cells making up the supportive tissue of the brain. Berubicin is an anthracycline, a class of drugs that are among the chemotherapy drugs, which intercalates into Deoxyribonucleic acid (DNA) and interrupts topoisomerase II activity. The company results in the inhibition of DNA replication and repair, and Ribonucleic acid (RNA) and protein synthesis.

Address: 2100 West Loop S Ste 900 Houston TEXAS 77027

Stay updated.